Literature DB >> 17060543

Endogenous testosterone levels, physical performance, and fall risk in older men.

Eric Orwoll1, Lori C Lambert, Lynn M Marshall, Janet Blank, Elizabeth Barrett-Connor, Jane Cauley, Kris Ensrud, Steven R Cummings.   

Abstract

BACKGROUND: Gonadal steroid levels decline with age in men. Whether low testosterone levels affect the development of common age-related disorders, including physical functioning and falling, is unclear.
METHODS: This longitudinal, observational follow-up study sought to determine whether low testosterone levels are associated with physical performance and fall risk in older men. A total of 2587 community-based men aged 65 to 99 years were selected using a stratified random sampling scheme from a study cohort of 5995 volunteers. Bioavailable testosterone and estradiol levels and physical performance measures were determined from baseline. Incident falls were ascertained every 4 months during 4 years of follow-up. Generalized estimating equations were used to estimate risk ratios for the relation of sex steroids to falls.
RESULTS: Fifty-six percent of the men reported at least 1 fall; many fell frequently. Lower bioavailable testosterone levels were associated with increased fall risk. Men with testosterone levels in the lowest quartile had a 40% higher fall risk than those in the highest quartile. The effect of low testosterone levels was most apparent in younger men (65-69 years) (relative risk, 1.8; 95% confidence interval, 1.2-2.7); testosterone level was not associated with falls in the oldest men (>/=80 years). Lower testosterone concentrations were associated with reduced physical performance. However, the association between low testosterone levels and fall risk persisted despite adjustment for performance.
CONCLUSIONS: Falls were common among older men. Fall risk was higher in men with lower bioavailable testosterone levels. The effect of testosterone level was independent of poorer physical performance, suggesting that the effect of testosterone on fall risk may be mediated by other androgen actions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060543     DOI: 10.1001/archinte.166.19.2124

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  64 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

3.  Testosterone Replacement Therapy and Rehospitalization in Older Men With Testosterone Deficiency in a Postacute Care Setting.

Authors:  Rasha A Al-Lami; James E Graham; Rachel R Deer; Jordan Westra; Stephen B Williams; Yong-Fang Kuo; Jacques Baillargeon
Journal:  Am J Phys Med Rehabil       Date:  2019-06       Impact factor: 2.159

4.  Novel strategies for improving physical function.

Authors:  Shalender Bhasin; Ravi Jasuja; Powen Tu; Thomas W Storer; Wen Guo
Journal:  Horm Res Paediatr       Date:  2011-07-21       Impact factor: 2.852

Review 5.  Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.

Authors:  Thomas W Storer; Renee Miciek; Thomas G Travison
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

6.  Inferior physical performance tests in 10,998 men in the MrOS study is associated with recurrent falls.

Authors:  Magnus K Karlsson; Eva Ribom; Jan-Åke Nilsson; Östen Ljunggren; Claes Ohlsson; Dan Mellström; Mattiaz Lorentzon; Hans Mallmin; Marcia Stefanick; Jodi Lapidus; Ping Chung Leung; Anthony Kwok; Elizabeth Barrett-Connor; Eric Orwoll; Björn E Rosengren
Journal:  Age Ageing       Date:  2012-08-24       Impact factor: 10.668

7.  Sex steroid hormone levels and body composition in men.

Authors:  Margaret A Gates; Rania A Mekary; Gretchen R Chiu; Eric L Ding; Gary A Wittert; Andre B Araujo
Journal:  J Clin Endocrinol Metab       Date:  2013-04-26       Impact factor: 5.958

8.  The Limited Clinical Utility of Testosterone, Estradiol, and Sex Hormone Binding Globulin Measurements in the Prediction of Fracture Risk and Bone Loss in Older Men.

Authors:  Eric S Orwoll; Jodi Lapidus; Patty Y Wang; Liesbeth Vandenput; Andrew Hoffman; Howard A Fink; Gail A Laughlin; Maria Nethander; Östen Ljunggren; Andreas Kindmark; Mattias Lorentzon; Magnus K Karlsson; Dan Mellström; Anthony Kwok; Sundeep Khosla; Timothy Kwok; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2016-11-14       Impact factor: 6.741

9.  Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men.

Authors:  Thomas W Storer; Shehzad Basaria; Tinna Traustadottir; S Mitchell Harman; Karol Pencina; Zhuoying Li; Thomas G Travison; Renee Miciek; Panayiotis Tsitouras; Kathleen Hally; Grace Huang; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

10.  Anemia and the risk of non-vertebral fractures: the Tromsø Study.

Authors:  L Jørgensen; T Skjelbakken; M-L Løchen; L Ahmed; A Bjørnerem; R Joakimsen; B K Jacobsen
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.